Indefinite Delivery Contract SPE2DB25D9640

The federal contract IDV award is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The IDC, under the SPE2DB program, is valid through November 2026 and enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The original solicitation, SPE2DE-23-R-0005, was issued by the DLA Troop Support Medical to establish a fixed-price IDIQ contract with Arthrex, Inc. for five years to supply orthopedic procedural packages, including hip, knee, shoulder, and trauma implants and instruments, as well as biologics. The contract aims to automate the procurement process through electronic ordering, invoicing, and delivery, with an estimated value of $269 million over the five-year period and a maximum potential value of $471 million. The contract is not associated with any set-aside designations, and performance will be in Philadelphia, Pennsylvania.